Unbiased AI-powered news
27 stories related to this topic, newest first.
Washington ExaminerOn May 14 the U.S. Supreme Court permitted continued distribution of mifepristone by mail into states with abortion restrictions. The order applies while litigation proceeds through the Fifth Circuit and possible Supreme Court review.
catholicnewsagency.comThe Supreme Court reversed a lower court order that would have restricted remote prescribing of mifepristone while a lawsuit proceeds. The decision maintains current access to the drug via telehealth and mail for medication abortion. Providers have prepared alternative regimens i…
abcnews.go.comThe Supreme Court on May 14, 2026, granted emergency requests to block a May 1 ruling by the 5th U.S. Circuit Court of Appeals that would have restricted mail access to mifepristone. The decision ensures the drug remains available without an in-person clinician appointment while…
New York PostThe Supreme Court on Thursday maintained nationwide access to mifepristone by mail and telehealth, setting aside a lower court order that would have required in-person dispensing while a Louisiana lawsuit against the FDA continues. The unsigned order keeps in place FDA rules rela…
upi.comMarty Makary stepped down as commissioner of the U.S. Food and Drug Administration on May 12, 2026. Pro-life organizations and Republican senators had pressed for months for a review of mifepristone and reinstatement of in-person dispensing requirements from the first Trump admin…
abcnews.go.comJustice Samuel A. Alito Jr. extended an administrative stay on May 11, 2026, pausing a U.S. Court of Appeals for the Fifth Circuit ruling against the Food and Drug Administration. Full access to mifepristone, including through telemedicine and the mail, will continue for at least…
cnbc.comThe Supreme Court is expected to take further action by the end of May 12, 2026 in a case involving mail orders of mifepristone, the abortion medication. A federal appeals court had ruled to stop such mail orders. The outcome could affect FDA regulatory authority over drug dispen…
washingtonpost.comStudents for Life America presented more than 13,000 signatures to DOJ officials on a rainy Thursday as frustration grows among pro-life groups with the Trump administration's approach to abortion policy. Supreme Court Justice Samuel Alito issued a temporary block on an appeals c…
Washington ExaminerThe Supreme Court on Monday extended an administrative stay keeping mifepristone available nationwide by mail and through telehealth. Justice Samuel Alito pushed the deadline to at least 5 p.m. Thursday while the court weighs an emergency appeal from two manufacturers against a 5…
StatThe Supreme Court must act by May 11 on emergency requests to maintain mail-order access to mifepristone or allow a lower court ruling reinstating in-person dispensing requirements to take effect. California abortion pill providers have readied workarounds using misoprostol alone…
Washington ExaminerThe Supreme Court on Monday extended an administrative stay allowing continued mail-order and telehealth prescriptions of mifepristone while it considers a challenge from Louisiana. Justice Samuel Alito issued the order, which prevents a 5th U.S. Circuit Court of Appeals ruling f…
Fox NewsAbortion pill suppliers in California are ready to immediately switch to misoprostol alone if the Supreme Court upholds restrictions on mailing mifepristone. The high court has temporarily stayed a lower court ruling that would have blocked telehealth prescriptions and mail deliv…
nypost.comPresident Trump has approved a plan to oust FDA administrator Marty Makary amid criticism from anti-abortion groups over the agency's handling of mifepristone, drug approvals and vaccines. An administration official confirmed the decision to The Independent, though no action has…
Washington ExaminerThe Supreme Court is examining an emergency petition from two mifepristone manufacturers seeking to overturn a 5th Circuit ruling that restored an in-person screening requirement for the abortion pill. Anti-abortion groups and 23 Republican-led states urged the justices to keep t…
The U.S. Food and Drug Administration issued a proposed rule this week to remove references to “gender” from its regulations. The agency cited a 2025 executive order from President Trump directing emphasis on biological sex across federal policies. The change has raised questions…
bbc.co.ukThe U.S. Supreme Court on Monday blocked a lower court ruling that would have ended mail and telehealth distribution of mifepristone. The stay lasts until next week while the high court reviews emergency appeals from the 5th U.S. Court of Appeals decision issued Friday. Cnn repor…
cnbc.comThe Supreme Court issued an order signed by Justice Samuel Alito that blocks a 5th U.S. Circuit Court of Appeals ruling restricting access to the abortion pill. The stay keeps mifepristone available by mail or pharmacy without an in-person visit through at least Monday while the…
The Supreme Court on May 5, 2026, placed a one-week hold on a 5th U.S. Circuit Court of Appeals decision blocking nationwide telemedicine prescriptions for mifepristone. Louisiana urged the justices to lift the hold while the Department of Justice filed no brief by the May 7 dead…
msnbc.comThe Supreme Court stayed a Fifth Circuit order blocking nationwide mail and telemedicine prescriptions of mifepristone through May 11, 2026. Louisiana urged the justices to allow the restrictions, while nearly two dozen Democratic-led states and former FDA leaders filed briefs de…
Fox NewsRepublican congressional leaders led by Sen. Bill Cassidy, Rep. Chris Smith, Senate Majority Leader John Thune and House Speaker Mike Johnson filed an amicus brief urging the Supreme Court to uphold the 5th U.S. Circuit Court of Appeals ruling reinstating in-person dispensing of…
cnbc.comThe Supreme Court on Monday placed a one-week hold on a May 1 decision by the 5th U.S. Circuit Court of Appeals that had restored a requirement for in-person dispensing of mifepristone nationwide. The stay allows telemedicine prescriptions and mailing of the drug to continue at l…
The FederalistThe U.S. Court of Appeals for the 5th Circuit granted Louisiana a stay that halts the Food and Drug Administration's mail-order distribution permissions for mifepristone. The decision follows a lawsuit citing state costs and health risks to women. The U.S. Supreme Court issued a…
shrm.orgThe U.S. Supreme Court issued a temporary stay on a lower court decision that blocked a federal rule allowing the abortion pill mifepristone to be mailed without an in-person doctor visit. Justice Samuel Alito granted the pause until May 11, 2026, giving time for responses in the…
manilatimes.netA pharmaceutical company producing the abortion pill mifepristone has appealed to the U.S. Supreme Court to block a federal appeals court ruling that prohibits mail-order distribution of the drug nationwide. The Fifth Circuit's decision restores in-person requirements for obtaini…
NprA U.S. appeals court issued an order on May 1, 2026, pausing FDA rules that allowed mifepristone to be obtained by mail or telemedicine. The decision, stemming from a Louisiana lawsuit, requires in-person dispensing nationwide. Stakeholders on both sides reacted, with the case li…
Substrate placeholder — needs reviewAnti-abortion organizations are pressing the U.S. Food and Drug Administration to expedite a review of mifepristone that could lead to restrictions on its prescription via telehealth. A recent federal court ruling in Louisiana highlighted ongoing legal challenges to FDA rules on…
NPRA U.S. federal judge in Louisiana ruled on Tuesday that the Food and Drug Administration must complete its review of mifepristone mailing restrictions, denying a preliminary block for now. The decision maintains national access to the abortion pill via mail and telehealth tempora…